Consultant/Senior consultant - Economic Modeling at Eli Lilly and Company

Bengaluru, Karnataka, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Advanced knowledge of economic modeling, including cost-effectiveness models (CEA/CUA), budget impact models (BIM), cost-minimization, and cost-consequence analyses
Proficiency in programming skills and use of economic modeling software/platforms
Strong understanding of Health Technology Assessment (HTA) requirements, local payer needs, and compliance standards
Knowledge of Health Outcomes research, including Real-World Evidence (RWE) and Patient Reported Outcomes (PRO) studies
Overarching view of compounds, therapeutic areas, external environment, and competitors
Ability to customize global models to local settings, adjusting parameters, costs, and clinical inputs
Skills in interpreting, communicating, and presenting modeling results, including technical reports, publications, and conference presentations
Experience leading early economic models for asset valuation, clinical trial design, and market access strategy
Capability to gather feedback, update models, and ensure quality standards
Adaptability in transitioning between model types and document preparation
Strong collaboration, influencing, negotiation, and risk mitigation skills with cross-functional teams and stakeholders
Continuous communication and customer focus with internal stakeholders

Responsibilities

Develop and adapt cost-effectiveness models (CEA/CUA), budget impact models (BIM), and other economic evaluations
Customize global economic models to local HTA/payer requirements, adjusting parameters, costs, and clinical inputs
Ensure models comply with internal quality standards and external HTA requirements
Lead development of early economic models for asset valuation, clinical trial design, and market access strategy
Interpret and communicate modeling results to stakeholders
Gather and integrate reviewer feedback to update models
Prepare detailed technical reports on objectives, analyses, results, findings, and conclusions
Participate in Global Economic Model Development, providing strategic solutions for business alignment
Contribute to publications and conference presentations based on modeling work
Collaborate with cross-functional teams to assess and mitigate model development risks
Influence/negotiate timelines and content with team members and stakeholders
Maintain and enhance economic modeling knowledge, programming skills, and Health Outcomes research awareness
Provide formal coaching, share technical expertise, and support knowledge sharing/best practices
Contribute to process improvements, automations, and team activities (rewards, teambuilding, diversity)
Work closely with stakeholders to understand requirements, ensure models meet needs, and maintain open communication

Skills

Health Technology Assessment

HTA

Cost Effectiveness Analysis

CEA

Cost Utility Analysis

CUA

Budget Impact Model

BIM

Economic Modeling

Cost Minimization

Cost Consequence Analysis

Model Development

Model Adaptation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free